Treatment strategies for Boerhaave syndrome: multinational retrospective cohort study
British Journal of Surgery · 29.11.2025 · 112 (12)
DOI: 10.1093/bjs/znaf260 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Surgery, online erschienen am 01.12.2025. Verfasst von Tobias Hauge und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Mediastinal Diseases, Esophageal Perforation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
Boerhaave syndrome is defined as a spontaneous perforation of the oesophagus. The mainstay of treatment is resuscitation of the patient, closure of the oesophageal defect, and drainage of perioesophageal and pleural fluid collections. Whether the optimal approach is endoscopic, surgical, or conservative management remains unknown and there are no clear guidelines. The aim of this multicentre retrospective cohort study was to evaluate current treatment strategies and outcomes for Boerhaave syndrome.
Methods
A multicentre retrospective analysis of data from 23 participating European tertiary centres was performed. Patients with Boerhaave syndrome treated between January 2019 and December 2023 were eligible for inclusion. The primary endpoint was the length of ICU stay and secondary endpoints included in-hospital mortality, 90-day mortality, and the length of overall hospital stay.
Results
In total, 216 patients were included; 151 were men (70%), the median age was 62 (22–95) years, and 81 (40%) were treated >24 h after the start of symptoms. Seventy (32%) patients were managed endoscopically (group I), 73 (34%) were managed surgically (group II), 67 (31%) were managed using a combination of endoscopy and surgery (group III), and 6 (3%) were managed using other methods (group IV). For patients in groups I–III: the median length of ICU stay was 8 (0–67) days, with no differences between the three groups (P = 0.105); the in-hospital mortality rate and 90-day mortality rate were both 12% (P = 0.490 and P = 0.637, respectively); and the median length of overall hospital stay was 27 (range 1–193) days, with the longest stays observed in patients who received combined treatment (P = 0.032).
Conclusion
This study provides a comprehensive overview of the current treatment strategies and outcomes for patients with Boerhaave syndrome in Europe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatric and Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.
- Department of General, Visceral, Thoracic and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany.
- Division of General and Foregut Surgery, IRCCS Policlinico San Donato, University of Milan, Milan, Italy.
- Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
- Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
- Department of General, Visceral and Paediatric Surgery, University Medical Centre Göttingen, Göttingen, Germany.
ORCID-Profile: Aram Abu Hejleh, Alberto Aiolfi, Luigi Bonavina, Xavier Benoit D'Journo, David Edholm, Wietse Eshuis, Peter Grimminger, Christian Alexander Gutschow, Bastiaan Klarenbeek, Fredrik Klevebro, Cezanne D Kooij, Misha Luyer, Henrik Nienhüser, Grard Nieuwenhuijzen, Ioannis Rouvelas, Marcel A Schneider, Michele Valmasoni, Elke van Daele, Richard van Hillegersberg, Sander J M van Hootegem, Hanne Vanommeslaeghe, Bas Wijnhoven, Magnus Nilsson
Zitieren
APA
Hauge, T., Abu Hejleh, A., Aiolfi, A., Berlth, F., Bonavina, L., Brake, L., Conradi, L. C., D'Journo, X. B., Edholm, D., Elliot, J., Eshuis, W., Friedrich, N., Gisbertz, S., Grimminger, P., Gutschow, C. A., Joglekar, S., Klarenbeek, B., Klevebro, F., Kooij, C. D., …, & Schröder, W. (2025). Treatment strategies for Boerhaave syndrome: multinational retrospective cohort study. British Journal of Surgery, 112(12). https://doi.org/10.1093/bjs/znaf260
Vancouver
Hauge T, Abu Hejleh A, Aiolfi A, Berlth F, Bonavina L, Brake L, et al. Treatment strategies for Boerhaave syndrome: multinational retrospective cohort study. British Journal of Surgery. 2025;112(12). doi:10.1093/bjs/znaf260
BibTeX
@article{Hauge2025,
author = {Hauge, Tobias and Abu Hejleh, Aram and Aiolfi, Alberto and Berlth, Felix and Bonavina, Luigi and Brake, Linda and Conradi, Lena-Christin and D'Journo, Xavier Benoit and Edholm, David and Elliot, Jessie and Eshuis, Wietse and Friedrich, Nora and Gisbertz, Suzanne and Grimminger, Peter and Gutschow, Christian Alexander and Joglekar, Shantanu and Klarenbeek, Bastiaan and Klevebro, Fredrik and Kooij, Cezanne D and Luyer, Misha and Milazzo, Alfio and Moletta, Lucia and Moons, Johnny and Moorthy, Krishna and Müller-Stich, Beat P and Nienhüser, Henrik and Nafteux, Philippe and Nezi, Giulia and Nico, Raphael and Neuschütz, Kerstin J and Nieuwenhuijzen, Grard and Raftery, Nicola and Renger, Franziska and Rouvelas, Ioannis and Ruurda, Jelle P and Schneider, Marcel A and Polette Stubb, Daniela and Todesco, Alban and Valmasoni, Michele and van Berge Henegouwen, Mark I and van Daele, Elke and van Hillegersberg, Richard and van Hootegem, Sander J M and Vanommeslaeghe, Hanne and Veziant, Julie and Wijnhoven, Bas and Vilela, João Pedro and Bruns, Christiane J and Nilsson, Magnus and Schröder, Wolfgang},
title = {Treatment strategies for Boerhaave syndrome: multinational retrospective cohort study},
journal = {British Journal of Surgery},
year = {2025},
volume = {112},
number = {12},
doi = {10.1093/bjs/znaf260}
}
EUVIMED